AOD 9604 Peptide Dosage for Beginners

Most beginner conversations about AOD 9604 peptide dosage land on 250–500 mcg per day, injected subcutaneously once daily, usually in the morning on an empty stomach. There is no officially approved beginner dose, because AOD-9604 is not FDA-approved for human use in the United States and is sold only as a research chemical. The numbers below come from published studies and community practice, not from a prescribing label.

What AOD-9604 Is and What It Is Not

AOD-9604 is a synthetic peptide built from the last 16 amino acids of human growth hormone, a fragment known as HGH 176-191. Researchers designed it to isolate the fat-metabolizing portion of growth hormone without the parts that raise blood sugar or drive tissue growth.

That difference matters for beginners. AOD-9604 does not appear to raise IGF-1 or growth hormone levels the way full HGH does, which is why it is usually discussed as a targeted fat-loss research peptide rather than a growth agent.

AOD-9604 is not FDA-approved for human use in the United States.

Typical AOD 9604 Peptide Dosage for Beginners

Beginner ranges are deliberately conservative. The usual advice is to start low, hold steady for one to two weeks, and only adjust if you are tracking side effects carefully.

• Starter dose: 250–300 mcg per day, injected subcutaneously.
• Common research range: 300–500 mcg per day.
• Higher range from older trials: 1 mg (1,000 mcg) per day, often taken orally.
• Frequency: once daily; some people split it into two smaller doses.
• Cycle length: 8–12 weeks, followed by a break.

Experience level	Daily amount	Notes
Beginner	250–300 mcg	Start here for 1–2 weeks to gauge tolerance
Standard research	300–500 mcg	Most frequently cited range in logs and forums
Higher research	1,000 mcg (1 mg)	Used in older clinical studies, usually oral

Body weight, training load, and individual response all change how a given amount feels in practice. People who are new to peptides often stay at the low end for the entire first cycle instead of escalating.

A written plan like this is often called an aod 9604 dosage protocol, and consistency matters far more than chasing bigger numbers.

Mixing, Dosing Math, and Injection Basics

Most AOD-9604 sold for research comes as a 5 mg lyophilized powder that has to be reconstituted before use. Adding 2 mL of bacteriostatic water to a 5 mg vial yields 2,500 mcg per mL, so a 300 mcg dose is a 0.12 mL draw, or 12 units on a U-100 insulin syringe.

Vial size	Diluent added	Concentration	300 mcg draw
5 mg	1 mL	5,000 mcg/mL	6 units (0.06 mL)
5 mg	2 mL	2,500 mcg/mL	12 units (0.12 mL)
2 mg	1 mL	2,000 mcg/mL	15 units (0.15 mL)

Learning how to use aod 9604 peptide safely starts with accurate reconstitution math and sterile technique. Some suppliers recommend acetic acid for aod 9604 because the peptide can dissolve slowly in plain water. Swirl the vial gently rather than shaking it, since foaming can damage the peptide chain.

Inject subcutaneously into the abdomen, thigh, or upper arm, and rotate sites daily. Alcohol swabs and a fresh needle are standard practice every single time.

Timing: When to Take AOD 9604 Peptide

The question of when to take aod 9604 peptide comes up constantly, and the most common answer is a fasted morning dose. Natural growth hormone output peaks overnight, and AOD-9604 is often used in that same fasted window.

• Morning, fasted: most common; wait 30–60 minutes before eating.
• Pre-workout: popular with people who train fasted.
• Before bed: chosen by some users to mimic the overnight GH pulse.

Whichever window you pick, keep it consistent. AOD-9604 has a short half-life, so a stable daily schedule appears to matter more than the exact hour.

Capsules, Side Effects, and Safety

Injectable vials are the most common format, but aod 9604 peptide capsules also exist. Oral versions were used in some older human trials, though absorption through the gut is generally considered lower and less predictable than subcutaneous injection.

Side effects reported in research settings were mostly mild: injection-site irritation, headache, and occasional nausea. Allergic reactions are possible, and anyone with a history of hormone-sensitive conditions should be cautious.

AOD-9604 is not approved as a human medication in the United States, and it is sold legally only for laboratory research. Anyone considering it should speak with a healthcare professional and get baseline bloodwork first.

Beginner Mistakes to Avoid

• Starting too high. Jumping straight to 1 mg raises the chance of side effects without proven extra benefit.
• Botching the math. Misreading concentration is the most common cause of an accidental overdose.
• Ignoring sterility. Reusing needles, sharing vials, or using tap water is never acceptable.
• Expecting overnight results. Most user logs describe gradual changes over 6–12 weeks, not days.
• Buying without testing. A third-party certificate of analysis is the only reliable check on purity.

Reported results vary widely between individuals, and no peptide replaces diet, training, and sleep.

COMMON QUESTIONS

Frequently Asked Questions

What is a good starting dose of AOD 9604 for a beginner?

Most beginner protocols start at 250–300 mcg per day, injected subcutaneously once daily. That is a conservative entry point taken from community practice rather than an approved label, since AOD-9604 has no FDA approval for human use. A healthcare professional should be involved before anyone begins.

How long does AOD 9604 take to work?

User reports and study timelines usually point to 4–8 weeks before noticeable changes, and 12-week research periods are common. AOD-9604 is not a rapid fat burner, and outcomes depend heavily on diet and activity level. Anyone expecting visible change within a few days will likely be disappointed.

Do AOD 9604 capsules work as well as injections?

Oral capsules were used in some older clinical trials, but absorption through the digestive tract is generally considered lower and less predictable than subcutaneous injection. Injectable vials remain the most common research format. Neither form is FDA-approved for human use in the United States.